101 related articles for article (PubMed ID: 9089710)
21. Targeting of a hydrophilic photosensitizer by use of internalizing monoclonal antibodies: A new possibility for use in photodynamic therapy.
Vrouenraets MB; Visser GW; Loup C; Meunier B; Stigter M; Oppelaar H; Stewart FA; Snow GB; van Dongen GA
Int J Cancer; 2000 Oct; 88(1):108-14. PubMed ID: 10962447
[TBL] [Abstract][Full Text] [Related]
22. Peptide linkers lead to modification of liver metabolism and improved tumor targeting of copper-67-labeled antibody fragments.
Novak-Hofer I; Zimmermann K; Schubiger PA
Cancer Biother Radiopharm; 2001 Dec; 16(6):469-81. PubMed ID: 11789024
[TBL] [Abstract][Full Text] [Related]
23. Comparative Evaluation of Using NOTA and DOTA Derivatives as Bifunctional Chelating Agents in the Preparation of
Guleria M; Das T; Amirdhanayagam J; Sarma HD; Dash A
Cancer Biother Radiopharm; 2018 Feb; 33(1):8-16. PubMed ID: 29373046
[TBL] [Abstract][Full Text] [Related]
24. Radioimmunoscintigraphy and radioimmunotherapy of renal cell carcinoma xenografts.
Vessella RL; Alvarez V; Chiou RK; Rodwell J; Elson M; Palme D; Shafer R; Lange P
NCI Monogr; 1987; (3):159-67. PubMed ID: 3821914
[TBL] [Abstract][Full Text] [Related]
25. In vitro and in vivo characterization of 64Cu-labeled Abegrin, a humanized monoclonal antibody against integrin alpha v beta 3.
Cai W; Wu Y; Chen K; Cao Q; Tice DA; Chen X
Cancer Res; 2006 Oct; 66(19):9673-81. PubMed ID: 17018625
[TBL] [Abstract][Full Text] [Related]
26. Tumor retention of 186Re-MAG3, 111In-DTPA and 125I labeled monoclonal antibody G250 in nude mice with renal cell carcinoma xenografts.
Steffens MG; Kranenborg MH; Boerman OC; Zegwaart-Hagemeier NE; Debruyne FM; Corstens FH; Oosterwijk E
Cancer Biother Radiopharm; 1998 Apr; 13(2):133-9. PubMed ID: 10850349
[TBL] [Abstract][Full Text] [Related]
27. Monoclonal antibodies in human renal cell carcinoma and their use in radioimmune localization and therapy of tumor xenografts.
Lange PH; Vessella RL; Chiou RK; Elson MK; Moon TD; Palme D; Shafer RK
Surgery; 1985 Aug; 98(2):143-50. PubMed ID: 4023915
[TBL] [Abstract][Full Text] [Related]
28. Antibody labeling with copper-67 using the bifunctional macrocycle 4-[(1,4,8,11-tetraazacyclotetradec-1-yl)methyl]benzoic acid.
Smith-Jones PM; Fridrich R; Kaden TA; Novak-Hofer I; Siebold K; Tschudin D; Maecke HR
Bioconjug Chem; 1991; 2(6):415-21. PubMed ID: 1805938
[TBL] [Abstract][Full Text] [Related]
29. In vivo evaluation of 177Lu- and 67/64Cu-labeled recombinant fragments of antibody chCE7 for radioimmunotherapy and PET imaging of L1-CAM-positive tumors.
Grünberg J; Novak-Hofer I; Honer M; Zimmermann K; Knogler K; Bläuenstein P; Ametamey S; Maecke HR; Schubiger PA
Clin Cancer Res; 2005 Jul; 11(14):5112-20. PubMed ID: 16033825
[TBL] [Abstract][Full Text] [Related]
30. A novel 177Lu-labeled porphyrin for possible use in targeted tumor therapy.
Das T; Chakraborty S; Sarma HD; Banerjee S; Venakatesh M
Nucl Med Biol; 2010 Jul; 37(5):655-63. PubMed ID: 20610170
[TBL] [Abstract][Full Text] [Related]
31. The impact of tumor size on the efficacy of monoclonal antibody-targeted radiotherapy: studies using a nude mouse model with human renal cell carcinoma xenografts.
Chiou RK
J Urol; 1991 Jul; 146(1):232-7. PubMed ID: 2056596
[TBL] [Abstract][Full Text] [Related]
32. [Radioimmunodetection of 188Re-labeled anti-carcinoembryonic antigen chimeric antibody in nude mice bearing human colon carcinoma].
Zhao ZG; Ran YL; Zheng R; Kong J; Chen SZ; Yu L; Yang ZH
Ai Zheng; 2002 May; 21(5):460-3. PubMed ID: 12452032
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studies.
Brouwers A; Mulders P; Oosterwijk E; Buijs W; Corstens F; Boerman O; Oyen W
Cancer Biother Radiopharm; 2004 Aug; 19(4):466-77. PubMed ID: 15453961
[TBL] [Abstract][Full Text] [Related]
34. Residualizing iodine markedly improved tumor targeting using bispecific antibody-based pretargeting.
van Schaijk FG; Broekema M; Oosterwijk E; van Eerd JE; McBride BJ; Goldenberg DM; Corstens FH; Boerman OC
J Nucl Med; 2005 Jun; 46(6):1016-22. PubMed ID: 15937314
[TBL] [Abstract][Full Text] [Related]
35. Monoclonal antibodies to human renal cell carcinoma: recognition of shared and restricted tissue antigens.
Vessella RL; Moon TD; Chiou RK; Nowak JA; Arfman EW; Palme DF; Peterson GA; Lange PH
Cancer Res; 1985 Dec; 45(12 Pt 1):6131-9. PubMed ID: 3904980
[TBL] [Abstract][Full Text] [Related]
36. Biodistribution study of 188Re-labeled trisuccin-HuCC49 and trisuccin-HuCC49deltaCh2 conjugates in athymic nude mice bearing intraperitoneal colon cancer xenografts.
Safavy A; Khazaeli MB; Safavy K; Mayo MS; Buchsbaum DJ
Clin Cancer Res; 1999 Oct; 5(10 Suppl):2994s-3000s. PubMed ID: 10541333
[TBL] [Abstract][Full Text] [Related]
37. Biodistribution of a benzoporphyrin derivative-monoclonal antibody conjugate in A549-tumor-bearing nude mice.
Jiang FN; Richter AM; Jain AK; Levy JG; Smits C
Biotechnol Ther; 1993; 4(1-2):43-61. PubMed ID: 8374512
[TBL] [Abstract][Full Text] [Related]
38. Study on biodistribution and radioimmunoimaging of (131)iodine-labeled monoclonal antibody D-D3 against progastrin-releasing peptide31-98 in tumor-bearing mouse.
Liu Z; Zhou X; Shi Y; Du S; Yang Y; Tang J; Shen Y
Cancer Biother Radiopharm; 2011 Apr; 26(2):229-35. PubMed ID: 21510749
[TBL] [Abstract][Full Text] [Related]
39. Comparison of four bifunctional chelates for radiolabeling monoclonal antibodies with copper radioisotopes: biodistribution and metabolism.
Rogers BE; Anderson CJ; Connett JM; Guo LW; Edwards WB; Sherman EL; Zinn KR; Welch MJ
Bioconjug Chem; 1996; 7(4):511-22. PubMed ID: 8853465
[TBL] [Abstract][Full Text] [Related]
40. A novel co-stimulatory T cell antigen co-expressed on renal cell carcinoma.
Labuda T; Lando P; Björkdahl O; Kalland T; Vessella R; Hedlund G; Eriksson H; Sjögren HO; Dohlsten M
Int Immunol; 1995 Sep; 7(9):1425-32. PubMed ID: 7495750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]